Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized Controlled Trial Comparing Cure Rates of Cervical Intraepithelial Neoplasia Grade 2 and Higher (CIN2+) Treated With CO2-based Cryotherapy, CropPen, and Thermoablation (UH3)

NCT03084081 is registered in ClinicalTrials.gov with The Cleveland Clinic as lead sponsor.

NCT NCT03084081
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03084081 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized Controlled Trial Comparing Cure Rates of Cervical Intraepithelial Neoplasia Grade 2 and Higher (CIN2+) Treated With CO2-based Cryotherapy, CropPen, and Thermoablation (UH3)
Lead sponsor
The Cleveland Clinic
Phase
Not applicable
Overall status
Completed
Start date
August 1, 2017
Completion date
August 15, 2024
Enrollment
1,132 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

cervical intraepithelial neoplasia